Historical Perspectives on Re-emerging Diseases

Throughout human history, infectious diseases have shaped civilizations, toppled empires, and altered the course of humanity. From ancient plagues that devastated entire populations to modern drug-resistant pathogens threatening global health security, the battle between humans and microbes continues to evolve. Understanding this historical perspective helps us appreciate both the remarkable progress we’ve made and the persistent challenges we face today.

Ancient pandemics that changed history 🔗

Long before modern medicine, infectious diseases wielded extraordinary power over human societies. Two particularly devastating examples from history illustrate how invisible pathogens could accomplish what armies alone could not.

Smallpox and the fall of the Aztec Empire 🔗

In 1519, Spanish conquistador Hernán Cortés arrived in Mexico with just a few hundred men, facing the mighty Aztec Empire with an estimated population of 16 million. Within two years, the capital city of Tenochtitlan had fallen. While Spanish weapons played a role, the true conqueror was far more microscopic-smallpox.

The disease arrived with European ships and spread rapidly through the indigenous population, who had no prior exposure or immunity to the virus. The smallpox epidemic reduced Tenochtitlan’s population by 40 percent in a single year, killing an estimated one-third to one-half of the entire Aztec population between 1520 and 1521. Survivors described the horror: entire families perished, homes became tombs, and bodies piled in the streets.

The epidemic struck at a crucial moment when the Aztecs had just forced the Spanish to retreat. The 60-day plague outbreak gave Cortés time to regroup while simultaneously destroying the Aztec social structure, leadership, and military capability. As one Franciscan chronicler grimly noted, the indigenous people died in heaps, not knowing how to treat this foreign disease.

The Black Death transforms Europe 🔗

Perhaps no pandemic in history rivals the sheer devastation of the Black Death, which swept across Europe from 1346 to 1353. Caused by the bacterium Yersinia pestis, the plague killed approximately 50 million people-around 60 percent of Europe’s entire population. To put this in perspective, this death toll exceeds the casualties of World War II and represents an unparalleled loss of human life as a proportion of the population.

The disease spread through a combination of rat fleas and extensive medieval trade networks. Ships carrying infected rats traveled at remarkable speeds for the time, spreading plague across vast distances. In some regions, mortality varied from one-eighth to two-thirds of the population, with cities like Florence and Siena losing 60 percent of their inhabitants within months.

The social and economic impacts were profound. Labor shortages transformed feudal relationships, wages increased for surviving workers, and entire villages disappeared. The plague reshaped European society, accelerating the transition from medieval to early modern civilization. Streets filled with corpses, families were torn apart, and the psychological trauma lingered for generations.

The triumph of vaccines and antimicrobials 🔗

The 20th century marked a dramatic turning point in humanity’s battle against infectious diseases. Scientific breakthroughs transformed diseases that had terrorized civilizations for millennia into preventable or curable conditions.

The vaccine revolution 🔗

Vaccines became one of the greatest public health achievements in history. Infectious diseases that caused major mortality in the early 20th century showed over a 90 percent decline in incidence by 2017, thanks to widespread vaccination programs. Smallpox, which had killed countless millions throughout history, was completely eradicated by 1977-the last naturally occurring case marked the end of a disease that had shaped human civilization.

Diseases like diphtheria, polio, measles, and mumps-once common childhood killers-became rare in countries with strong vaccination programs. The introduction of vaccines for these diseases meant that children who would have died or been permanently disabled could now grow up healthy. In the United States alone, vaccination of a single annual birth cohort against 13 diseases prevented an estimated 20 million cases of disease and 42,000 deaths.

The antimicrobial era 🔗

The discovery of antimicrobial agents was one of the greatest contributions to medicine in the 20th century. Antibiotics made it possible to cure tuberculosis, which had been a persistent killer throughout history. Diseases like pneumonia, once a death sentence, became treatable with penicillin and other antibiotics.

Combined with improved sanitation, better nutrition, and public health measures, these medical advances dramatically increased life expectancy. The mortality rate from infectious diseases in developed countries plummeted from 797 deaths per 100,000 in 1900 to just 59 per 100,000 by 1996. Chronic diseases like heart disease and cancer, rather than infections, became the leading causes of death-a complete reversal from earlier centuries.

Modern threats: the return of old enemies 🔗

Despite remarkable progress, infectious diseases have not been defeated. In fact, some are making alarming comebacks, resistant to the very drugs that once controlled them.

Multidrug-resistant tuberculosis 🔗

Multidrug-resistant tuberculosis (MDR-TB) represents one of the most urgent challenges in global TB control. In 2023, an estimated 400,000 people developed MDR-TB or rifampicin-resistant TB worldwide, with only two in five receiving treatment. This form of TB resists the two most powerful first-line drugs-isoniazid and rifampicin-making it extremely difficult and expensive to treat.

The emergence of extensively drug-resistant TB (XDR-TB) is even more concerning. These strains resist not only the first-line drugs but also fluoroquinolones and second-line injectable medications, leaving patients with very limited treatment options. The highest rates are found in Eastern Europe and Central Asia, where MDR strains threaten to become as common as drug-susceptible strains. Treatment requires at least 18 months of complex drug regimens, often with severe side effects, and success rates remain worryingly low.

Artemisinin-resistant malaria 🔗

Malaria, which kills hundreds of thousands annually, faces a new threat: resistance to artemisinin-based combination therapies (ACTs), the most effective antimalarial drugs available. Artemisinin partial resistance has been confirmed in multiple African countries including Rwanda, Uganda, Tanzania, and Eritrea, where the malaria burden is highest.

The resistance first emerged in Southeast Asia’s Greater Mekong Subregion and has now appeared independently in Africa. Parasites with resistance mutations show delayed clearance after treatment, increasing the risk of treatment failure. What makes this especially alarming is that Africa accounts for 90 percent of global malaria cases and deaths. If ACTs fail widely in Africa, millions of children could be at risk.

The CDC warns that partial artemisinin resistance has independently emerged in parts of Southeast Asia, South America, and East Africa, threatening the efficacy of the main class of antimalarials used worldwide. Unlike smallpox, which humans eradicated through vaccination, malaria parasites continue to evolve and adapt, finding new ways to survive.

Lessons from history, challenges for today 🔗

The historical perspective reveals a clear pattern: humanity has made extraordinary progress against infectious diseases, yet complacency remains our greatest vulnerability. Ancient pandemics like smallpox and plague shaped entire civilizations, killing millions and altering the course of history. The 20th century brought unprecedented victories through vaccines and antibiotics, dramatically reducing infectious disease mortality.

However, the emergence of drug-resistant diseases like MDR-TB and artemisinin-resistant malaria demonstrates that the battle continues. These modern threats remind us that microbes evolve, adapt, and exploit weaknesses in our defenses. The same global connectivity that helps spread medical knowledge and treatments also facilitates the rapid spread of resistant pathogens.

History teaches us that infectious diseases have repeatedly reshaped human civilization-sometimes catastrophically. Our current advantages of modern medicine, surveillance systems, and global coordination are powerful, but they require constant vigilance and investment. The question is not whether new infectious threats will emerge, but how prepared we will be to face them.

What do you think? Given the historical pattern of pandemics reshaping societies, how should modern governments balance investments in pandemic preparedness against other pressing needs? Has the convenience of antibiotics made us too complacent about the threat of antimicrobial resistance?

References

1. https://www.pbs.org/newshour/science/how-smallpox-devastated-the-aztecs-and-helped-spain-conquer-an-american-civilization-500-years-ago
2. https://www.historytoday.com/archive/black-death-greatest-catastrophe-ever
3. https://www.britannica.com/event/Black-Death
4. https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2023.1326154/full
5. https://history.missouri.edu/node/141
6. https://www.who.int/news-room/questions-and-answers/item/tuberculosis-multidrug-resistant-tuberculosis-(mdr-tb)
7. https://www.who.int/news-room/questions-and-answers/item/artemisinin-resistance
8. https://www.cdc.gov/malaria/php/public-health-strategy/drug-resistance.html